Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

Clinical trial NCT02029690 · TERMINATED

Trial details

NCT number: NCT02029690
Sponsor: Polaris Group
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Pleural Mesothelioma Malignant Advanced Peritoneal Mesothelioma Malignant Advanced Non-squamous Non-small Cell Lung Carcinoma Uveal Melanoma Hepatocellular Carcinoma Glioma Sarcomatoid Carcinoma

Start date: 2014-04-23
Primary completion: 2018-08-15
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.